Burgess, David S.

Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test

White, R. L., Burgess, D. S., Manduru, M., & Bosso, J. A. (1996) · Antimicrobial Agents and Chemotherapy

Bacterial Identification and Susceptibility TestingAntibiotic Resistance in Bacteria

Cited by 721

Single dose and multiple dose studies of itraconazole nanoparticles

Vaughn, J. M., McConville, J. T., Burgess, D., Peters, J. I., Johnston, K. P., Talbert, R. L., & Williams, R. O. (2006) · European Journal of Pharmaceutics and Biopharmaceutics

Inhalation and Respiratory Drug DeliveryAdvanced Drug Delivery Systems

Cited by 85

Increases in SLT2 Expression and Chitin Content Are Associated with Incomplete Killing of Candida glabrata by Caspofungin

Cota, J. M., Grabinski, J. L., Talbert, R. L., Burgess, D. S., Rogers, P. D., Edlind, T. D., & Wiederhold, N. P. (2008) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 69

Key issues concerning fungistatic versus fungicidal drugs

Graybill, J. R., Burgess, D. S., & Hardin, T. C. (1997) · European Journal of Clinical Microbiology & Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 59

Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans

NASH, J. D., BURGESS, D. S., & TALBERT, R. L. (2002) · Journal of Medical Microbiology

Antifungal resistance and susceptibilityCancer, Lipids, and Metabolism

Cited by 44

Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis

Alvarez, C. A., Wiederhold, N. P., McConville, J. T., Peters, J. I., Najvar, L. K., Graybill, J. R., Coalson, J. J., Talbert, R. L., Burgess, D. S., Bocanegra, R., et al. (2007) · Journal of Infection

Antifungal resistance and susceptibilityInhalation and Respiratory Drug Delivery

Cited by 43